Albert Einstein College of Medicine (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
132
Publications
2096
Citations
71686
i10-index
746
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Azacitidine and Venetoclax in Previously Untreated... | 2020 | 2771 |
Venetoclax combined with decitabine or azacitidine... | 2018 | 1852 |
Targetable Kinase-Activating Lesions in Ph-like Ac... | 2014 | 1376 |
Efficacy and Biological Correlates of Response in ... | 2016 | 1056 |
Mechanisms of apoptosis sensitivity and resistance... | 2006 | 1011 |
An inhibitor of oxidative phosphorylation exploits... | 2018 | 951 |
Acute myeloid leukemia: current progress and futur... | 2021 | 761 |
Selective BCL-2 Inhibition by ABT-199 Causes On-Ta... | 2013 | 735 |
2021 Update on MRD in acute myeloid leukemia: a co... | 2021 | 719 |
Safety and preliminary efficacy of venetoclax with... | 2018 | 712 |
Marina Konopleva is a researcher with 2096 publications and 71686 citations. They are affiliated with Albert Einstein College of Medicine. Their research focuses on . With an h-index of 132, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Marina Konopleva and 250M+ other papers.
Citations per publication by year